FDA approves new sleeping drug from Merck - Los Angeles News | FOX 11 LA KTTV

FDA approves new sleeping drug from Merck

Posted: Updated:

WASHINGTON (AP) -- Merck & Co. Inc. has won federal approval for a new type of sleeping pill designed to help people with insomnia stay asleep.

The tablet, Belsomra, works by temporarily blocking chemicals known as orexins that control the sleep cycle and can keep people awake at night. It's unclear whether the new drug is safer or more effective than older drugs because it was tested against a dummy pill, rather than other sleeping medications.

The Food and Drug Administration approved the drug Wednesday in four different doses for various degrees of insomnia. The agency noted that patients who took the highest dose, 20 milligrams, experienced drowsiness and difficulty driving the next morning.

Doctors should warn patients taking the highest dose against next-day driving or activities that require full concentration, the FDA said. It added that side effects such as next-day drowsiness can be reduced by using the lowest effective dose. Drowsiness is a side effect listed on the labels of all anti-insomnia drugs.

In the last year, the FDA lowered the recommended dosage on Ambien, Lunesta and related drugs based on studies showing a link to driving problems and impaired memory and coordination. The agency cited research showing that the drugs remain in the bloodstream at levels high enough to interfere with activities that require focus and attention.

The FDA is requiring that patients who get the new drug receive a medication guide detailing the drug's potential safety issues, including sleep-walking, sleep-driving and other semi-awake activities.

The agency said it approved Belsomra based on three company studies involving 500 patients that showed people taking it fell asleep faster and spent less time awake compared with people taking a dummy pill.

Like other prescription sleeping drugs, Belsomra is designed to be taken only once per night and only when patients have at least seven hours before they need to wake up.

Shares of Merck & Co. Inc., which is based in Whitehouse Station, New Jersey, rose 82 cents, or 1.4 percent, to close at $57.85.

© 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

  • Latest health newsMore>>

  • Kids' poisonings linked to anti-addiction medicine

    Kids' poisonings linked to anti-addiction medicine

    Monday, September 15 2014 9:31 AM EDT2014-09-15 13:31:20 GMT
    CHICAGO (AP) -- An anti-addiction drug used to fight the nation's heroin and painkiller abuse epidemics poses a threat to young children who accidentally swallow relatives' prescriptions, a federal study says. Some children have died. The study found that the drug, buprenorphine, was the adult prescription medication most commonly implicated in emergency hospitalizations of children aged 6 and younger. For every 100,000 patients prescribed buprenorphine, 200 young children were hospitalized ...
    CHICAGO (AP) -- An anti-addiction drug used to fight the nation's heroin and painkiller abuse epidemics poses a threat to young children who accidentally swallow relatives' prescriptions, a federal study says. Some children have died. The study found that the drug, buprenorphine, was the adult prescription medication most commonly implicated in emergency hospitalizations of children aged 6 and younger. For every 100,000 patients prescribed buprenorphine, 200 young children were hospitalized ...
  • Race for Every Child: Elliott's Story

    Race for Every Child: Elliott's Story

    Friday, September 12 2014 8:50 PM EDT2014-09-13 00:50:04 GMT
    Having a child with a serious illness or disability is overwhelming. Imagine dealing with that crisis and not really having many answers about how to treat it or what the future holds.
    Having a child with a serious illness or disability is overwhelming. Imagine dealing with that crisis and not really having many answers about how to treat it or what the future holds.
  • 'Cancer Boy' now cancer-free and publishing book with his classmates

    'Cancer Boy' now cancer-free and publishing book with his classmates

    Tuesday, September 9 2014 9:05 PM EDT2014-09-10 01:05:59 GMT
    We have a very happy follow up to a story we brought you last year. It is the story of a young Virginia boy who had a brain tumor. We were touched by the love his classmates showed him and they are still spreading love.
    We have a very happy follow up to a story we brought you last year. It is the story of a young Virginia boy who had a brain tumor. We were touched by the love his classmates showed him and they are still spreading love.
Powered by WorldNow

KTTV FOX 11
1999 S. Bundy Dr.
Los Angeles CA 90025

Main: (310) 584-2000
News Tips? (310) 584-2025

Didn't find what you were looking for?
All content © Copyright 2000 - 2014 Fox Television Stations, Inc. and Worldnow. All Rights Reserved.
Privacy Policy | New Terms of Service What's new | Ad Choices